Letter: the effect of sirolimus on recurrence and survival in liver transplant recipients with hepatocellular carcinoma-authors' reply

被引:0
|
作者
Menon, Krishna V. [1 ]
Hakeem, Abdul R. [2 ]
Heaton, Nigel D. [1 ]
机构
[1] Kings Coll Hosp London, Inst Liver Studies, London, England
[2] Addenbrookes Univ Hosp, Dept HPB & Transplant Surg, Cambridge, England
关键词
IMMUNOSUPPRESSION;
D O I
10.1111/apt.15038
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1331 / 1332
页数:2
相关论文
共 50 条
  • [1] Letter: the effect of sirolimus on recurrence and survival in liver transplant recipients with hepatocellular carcinoma
    Grigg, Sam
    Gow, Paul J.
    Yeomans, Neville
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (11-12) : 1330 - 1331
  • [2] Editorial: frequency of surveillance and survival in hepatocellular carcinoma-authors' reply
    Kim, H. Y.
    Lee, J. -H.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (02) : 229 - 230
  • [3] Sirolimus in Liver Transplant Recipients With Hepatocellular Carcinoma
    Grigg, Sam
    Gow, Paul
    Yeomans, Neville
    [J]. JOURNAL OF INVESTIGATIVE SURGERY, 2020, 33 (04) : 389 - 390
  • [4] Letter: sequential or combined systemic treatment for unresectable hepatocellular carcinoma-authors' reply
    Kirstein, Martha M.
    Scheiner, Bernhard
    Pinter, Matthias
    Vogel, Arndt
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (05) : 917 - 918
  • [5] Letter: association between proton pump inhibitors and the risk of hepatocellular carcinoma-authors' reply
    Shao, Yu-Hsuan Joni
    Wu, Szu-Yuan
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (10) : 1165 - 1166
  • [6] Letter: liver dysfunction and survival in hepatocellular carcinoma treated by transarterial chemoembolisation - authors' reply
    Cabibbo, G.
    Genco, C.
    Camma, C.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (07) : 862 - 863
  • [7] SURVIVAL AND RECURRENCE OF HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANT
    Mitlyng, B.
    Smith, C.
    [J]. JOURNAL OF HEPATOLOGY, 2010, 52 : S227 - S227
  • [8] Editorial: redrawing the boundaries for surgical intervention in hepatocellular carcinoma-authors' reply
    Wang, Yan-Yan
    Zhong, Jian-Hong
    Mao, Yi-Lei
    Li, Le-Qun
    Xing, Bao-Cai
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (05) : 616 - 617
  • [9] Letter: programmed cell death protein-1-targeted immunotherapy for advanced hepatocellular carcinoma-authors' reply
    Scheiner, Bernhard
    Pinter, Matthias
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (03) : 341 - 342
  • [10] Sirolimus in Liver Transplant Recipients with Hepatocellular Carcinoma: An Updated Meta-Analysis
    Zhang, Zhi-Hua
    Li, Li Xin
    Li, Ping
    Lv, Shao-Cheng
    Pan, Bing
    He, Qiang
    [J]. JOURNAL OF INVESTIGATIVE SURGERY, 2019, 32 (07) : 632 - 641